15 results
8-K
EX-3.1
ADVM
Adverum Biotechnologies, Inc.
20 Mar 24
Material Modifications to Rights of Security Holders
4:13pm
8-K
EX-3.2
ADVM
Adverum Biotechnologies, Inc.
20 Mar 24
Material Modifications to Rights of Security Holders
4:13pm
8-K
EX-3.1
ADVM
Adverum Biotechnologies, Inc.
29 Jun 20
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.1
ADVM
Adverum Biotechnologies, Inc.
16 Dec 19
Departure of Directors or Certain Officers
12:00am
10-K
2016 FY
EX-3.1
ADVM
Adverum Biotechnologies, Inc.
Annual report
9 Mar 17
12:00am
8-K
EX-3.1
hyl 5t549a2gk0l6l
12 May 16
Avalanche Biotechnologies Closes Transaction with Annapurna Therapeutics and Changes Name to Adverum Biotechnologies
12:00am
8-K
EX-3.2
13zhx9xq 73bpn
12 May 16
Avalanche Biotechnologies Closes Transaction with Annapurna Therapeutics and Changes Name to Adverum Biotechnologies
12:00am
8-K
EX-3.1
1stojuye575kup
6 Aug 14
Avalanche Biotechnologies Announces Closing of Initial Public Offering
12:00am
8-K
EX-3.2
qgqw6sl esu65y4z2c
6 Aug 14
Avalanche Biotechnologies Announces Closing of Initial Public Offering
12:00am
S-1
EX-3.3
tue t61he80978m5xhx
30 Jun 14
IPO registration
12:00am
S-1
EX-3.1
lngqg0
30 Jun 14
IPO registration
12:00am
DRS
EX-3
bt3bw8r1 g1
30 May 14
Draft registration statement
12:00am
DRS
EX-3
tldg1v yk98t7og
30 May 14
Draft registration statement
12:00am
- Prev
- 1
- Next